↓ Skip to main content

Dove Medical Press

Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats

Overview of attention for article published in International Journal of Nanomedicine, June 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
5 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
71 Mendeley
Title
Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats
Published in
International Journal of Nanomedicine, June 2016
DOI 10.2147/ijn.s107292
Pubmed ID
Authors

Mireia Campos-Martorell, Mary Cano-Sarabia, Alba Simats, Mar Hernández-Guillamon, Anna Rosell, Daniel Maspoch, Joan Montaner

Abstract

Although the beneficial effects of statins on stroke have been widely demonstrated both in experimental studies and in clinical trials, the aim of this study is to prepare and characterize a new liposomal delivery system that encapsulates simvastatin to improve its delivery into the brain. In order to select the optimal liposome lipid composition with the highest capacity to reach the brain, male Wistar rats were submitted to sham or transitory middle cerebral arterial occlusion (MCAOt) surgery and treated (intravenous [IV]) with fluorescent-labeled liposomes with different net surface charges. Ninety minutes after the administration of liposomes, the brain, blood, liver, lungs, spleen, and kidneys were evaluated ex vivo using the Xenogen IVIS(®) Spectrum imaging system to detect the load of fluorescent liposomes. In a second substudy, simvastatin was assessed upon reaching the brain, comparing free and encapsulated simvastatin (IV) administration. For this purpose, simvastatin levels in brain homogenates from sham or MCAOt rats at 2 hours or 4 hours after receiving the treatment were detected through ultra-high-protein liquid chromatography. Whereas positively charged liposomes were not detected in brain or plasma 90 minutes after their administration, neutral and negatively charged liposomes were able to reach the brain and accumulate specifically in the infarcted area. Moreover, neutral liposomes exhibited higher bioavailability in plasma 4 hours after being administered. The detection of simvastatin by ultra-high-protein liquid chromatography confirmed its ability to cross the blood-brain barrier, when administered either as a free drug or encapsulated into liposomes. This study confirms that liposome charge is critical to promote its accumulation in the brain infarct after MCAOt. Furthermore, simvastatin can be delivered after being encapsulated. Thus, simvastatin encapsulation might be a promising strategy to ensure that the drug reaches the brain, while increasing its bioavailability and reducing possible side effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Unknown 70 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 23%
Student > Bachelor 11 15%
Student > Master 8 11%
Researcher 7 10%
Librarian 2 3%
Other 7 10%
Unknown 20 28%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 11 15%
Biochemistry, Genetics and Molecular Biology 7 10%
Agricultural and Biological Sciences 6 8%
Medicine and Dentistry 6 8%
Engineering 6 8%
Other 10 14%
Unknown 25 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2020.
All research outputs
#6,786,653
of 25,470,300 outputs
Outputs from International Journal of Nanomedicine
#709
of 4,130 outputs
Outputs of similar age
#101,155
of 353,832 outputs
Outputs of similar age from International Journal of Nanomedicine
#18
of 123 outputs
Altmetric has tracked 25,470,300 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 4,130 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,832 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.